Allarity Therapeutics, Inc. Stock Nasdaq Stockholm
Equities
ALLR
US0167441049
Biotechnology & Medical Research
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 476K 5.2M |
---|---|---|---|---|---|
Net income 2024 * | -16M -175M | Net income 2025 * | -28M -306M | EV / Sales 2024 * | - |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-0.05
x | P/E ratio 2025 * |
-0.05
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.98% |
Latest transcript on Allarity Therapeutics, Inc.
Managers | Title | Age | Since |
---|---|---|---|
Thomas Jensen
FOU | Founder | 46 | 20-05-31 |
Joan Brown
DFI | Director of Finance/CFO | 71 | 21-09-20 |
Chief Tech/Sci/R&D Officer | 63 | 21-06-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 56 | 22-09-30 | |
Thomas Jensen
FOU | Founder | 46 | 20-05-31 |
Joseph Vazzano
BRD | Director/Board Member | 40 | 23-07-31 |
1st Jan change | Capi. | |
---|---|---|
-3.10% | 102B | |
+2.11% | 96.07B | |
-1.80% | 21.66B | |
-17.75% | 20.77B | |
-6.91% | 18.53B | |
-42.00% | 16.91B | |
-28.19% | 13.79B | |
+0.18% | 13.33B | |
+19.90% | 10.94B |